重型COVID-19患者血小板活化与部分脱敏与病毒异源自噬相关
该前瞻性队列纳入29例重症监护病房的重型COVID-19患者,检测血小板参数及血小板内病毒物质。结果发现患者血小板高表达活化和炎症标志物,血小板部分脱敏,电镜和免疫标记证实血小板内存在SARS-CoV-2颗粒,且血小板通过异源自噬消化病毒物质。
要点
- 重型COVID-19患者血小板活化标志物升高,伴炎症因子及白细胞-血小板相互作用增加。
- 患者血小板对刺激的αIIbβ3活化和颗粒分泌显著降低,表面GPVI减少,呈部分脱敏。
- 电镜及免疫标记证实血小板内存在SARS-CoV-2颗粒,LC3与Spike共定位提示异源自噬。
核心结论
- 重型COVID-19期间血小板被活化、部分脱敏并产生选择性自噬反应。
研究设计与样本
- 前瞻性队列研究,纳入29例入住重症监护病房的重型COVID-19患者。
主要发现
- 重型COVID-19患者血浆中蛋白和脂质血小板活化标志物水平高,伴促炎细胞因子及白细胞-血小板相互作用增加。
- 患者血小板对刺激的αIIbβ3活化和颗粒分泌显著降低,表面GPVI减少,呈部分脱敏。
- 重型COVID-19患者血浆增强洗涤健康血小板的聚集反应。
- 透射电镜、免疫金标记及Spike和核衣壳蛋白免疫荧光成像证实部分血小板内存在SARS-CoV-2颗粒。
- 与健康供者或细菌性脓毒症患者血小板相比,重型COVID-19患者血小板内囊泡和自噬溶酶体增大,LC3阳性结构增大,LC3II水平升高,LC3与Spike共定位。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Mild thrombocytopenia, changes in platelet gene expression, enhanced platelet functionality, and presence of platelet-rich thrombi in the lung have been associated with thromboinflammatory complications of patients with COVID-19. However, whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) gets internalized by platelets and directly alters their behavior and function in infected patients remains elusive. Here, we investigated platelet parameters and the presence of viral material in platelets from a prospective cohort of 29 patients with severe COVID-19 admitted to an intensive care unit. A combination of specific assays, tandem mass spectrometry, and flow cytometry indicated high levels of protein and lipid platelet activation markers in the plasma from patients with severe COVID-19 associated with an increase of proinflammatory cytokines and leukocyte-platelets interactions. Platelets were partly desensitized, as shown by a significant reduction of αIIbβ3 activation and granule secretion in response to stimulation and a decrease of surface GPVI, whereas plasma from patients with severe COVID-19 potentiated washed healthy platelet aggregation response. Transmission electron microscopy indicated the presence of SARS-CoV-2 particles in a significant fraction of platelets as confirmed by immunogold labeling and immunofluorescence imaging of Spike and nucleocapsid proteins. Compared with platelets from healthy donors or patients with bacterial sepsis, platelets from patients with severe COVID-19 exhibited enlarged intracellular vesicles and autophagolysosomes. They had large LC3-positive structures and increased levels of LC3II with a co-localization of LC3 and Spike, suggesting that platelets can digest SARS-CoV-2 material by xenophagy in critically ill patients. Altogether, these data show that during severe COVID-19, platelets get activated, become partly desensitized, and develop a selective autophagy response.
引用
- Garcia C, Au Duong J, Poëtte M, et al. Platelet activation and partial desensitization are associated with viral xenophagy in patients with severe COVID-19. Blood Adv. 2022. PMID: 35789374. doi:10.1182/bloodadvances.2022007143
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。